MBL2 and infection: However, our results did support those found by Neth et al. [23], which suggested that donors’ MBL2 genotype did not influence infection rates, and the results of Rocha et al. [21], who examined 107 HLA identical sibling Allo-HSCT recipients with myeloablative conditioning and found no association between MBL2 gene polymorphisms and the development of bacterial, viral or fungal infections during the first 180 days after transplant.